Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates-Reference-Cited by-同舟云学术

Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates

Published:2019-04 Issue: Volume:369 Page:1-16
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Geven Christopher,Kox Matthijs,Blet Alice,Mebazaa Alexandre,Schroedter Mathias,Struck Joachim,Bergmann Andreas,Pickkers Peter

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference25 articles.

1. Adrenomedullin reduces Staphylococcus aureus alpha-toxin-induced rat ileum microcirculatory damage;Brell;Crit. Care Med.,2005

2. Circulating biologically active adrenomedullin (bio-ADM) predicts hemodynamic support requirement and mortality during sepsis;Caironi;Chest,2017

3. Guide for the Care and Use of Laboratory Animals;Committee for the Update of the Guide for the Care and Use of Laboratory Animals, National Research Council of the National Academies,2011

4. Sepsis: current dogma and new perspectives;Deutschman;Immunity,2014

5. Assessment of global incidence and mortality of hospital-treated Sepsis. Current estimates and limitations;Fleischmann;Am. J. Respir. Crit. Care Med.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absorption, metabolism and bioavailability of flavonoids: a review;Critical Reviews in Food Science and Nutrition;2021-06-03

2. Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis;Expert Opinion on Investigational Drugs;2020-12-21

3. Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations;Regulatory Toxicology and Pharmacology;2020-10

4. New Agents in Development for Sepsis: Any Reason for Hope?;Drugs;2020-09-20